STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Charles River Laboratories (CRL): Schedule 13G/A reports that Nomura Holdings, Inc. beneficially owns 807,923 shares of CRL common stock, equal to 1.6% of the class. The ownership is held with sole voting and dispositive power and is attributed to Nomura subsidiaries Nomura Global Financial Products, Inc., Nomura Securities International, Inc., and Nomura International PLC.

The percentage is based on 49,215,000 shares outstanding as of September 27, 2025. Nomura certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Sole voting and dispositive power represents (i) 806,275 shares of Common Stock beneficially owned by Nomura Global Financial Products, Inc. ("NGFP"), (ii) 468 shares of Common Stock beneficially owned by Nomura Securities International, Inc. ("NSI"), and (iii) 1,180 shares of Common Stock beneficially owned by Nomura International PLC ("NIP"). NGFP, NSI and NIP are wholly owned subsidiaries of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the shares of Common Stock beneficially owned by NGFP, NSI and NIP. (2) The percent of class is calculated based on 49,215,000 shares of Common Stock outstanding as of September 27, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 27, 2025 filed with the SEC on November 5, 2025.


SCHEDULE 13G



NOMURA HOLDINGS INC
Signature:/s/ Samir Patel
Name/Title:Samir Patel, Managing Director
Date:11/14/2025
Exhibit Information

Exhibit A - Subsidiaries

FAQ

What did Nomura disclose in its Schedule 13G/A for CRL?

Nomura Holdings, Inc. reported beneficial ownership of 807,923 CRL shares, representing 1.6% of the outstanding common stock.

How was the 1.6% ownership in CRL calculated?

It was calculated using 49,215,000 shares outstanding as of September 27, 2025, as reported by the issuer.

Does Nomura have voting and dispositive power over the CRL shares?

Yes. Nomura reports sole voting power and sole dispositive power over 807,923 shares.

Which Nomura subsidiaries hold the CRL shares?

Shares are beneficially owned by NGFP (806,275), NSI (468), and NIP (1,180), all wholly owned by Nomura Holdings, Inc.

What certification did Nomura include about its CRL holdings?

Nomura certified the shares were acquired and are held in the ordinary course of business and not to influence control.

What is the date of the event requiring this filing?

The event date is September 30, 2025.
Charles Riv Labs Intl Inc

NYSE:CRL

CRL Rankings

CRL Latest News

CRL Latest SEC Filings

CRL Stock Data

8.33B
48.60M
1%
105.66%
5.42%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON